Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Vebanvibart, an antibody targeting SARS-CoV-2 Spike RBD.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Umikibart, an antibody targeting HGF.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ucenprubart, an antibody targeting MOX2R.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Traxivitug, an antibody targeting BK Polyomavirus Major Capsid Protein VP1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Pacibekitug, an antibody targeting IL6.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ozureprubart, an antibody targeting IgE.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ocankitug, an antibody targeting TSLP.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Obrixtamig, an antibody targeting DLL3 × CD3E.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Negalstobart, an antibody targeting LAG-3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Navenibart, an antibody targeting Plasma kallikrein.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Misitatug, an antibody targeting MSLN.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Lumrotatug, an antibody targeting ADPRC1.